Chronic Myeloid Leukemia News and Research

RSS
Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. According to the American Cancer Society, CML is a type of cancer that starts in blood-forming cells of the bone marrow and then invades the blood. It can spread to the lymph nodes, spleen, liver, and other parts of the body. CML can also change into a fast-growing acute leukemia that invades almost any organ in the body.
OHSU Knight Cancer Institute Director wins 2018 Tang Prize in Biopharmaceutical Science

OHSU Knight Cancer Institute Director wins 2018 Tang Prize in Biopharmaceutical Science

Study: Single surface protein can amplify multiple key pathways in acute myeloid leukemia

Study: Single surface protein can amplify multiple key pathways in acute myeloid leukemia

Interfering with enzyme's movement may be new approach for developing of anti-cancer drugs

Interfering with enzyme's movement may be new approach for developing of anti-cancer drugs

Researchers test new cancer research model that may reduce cost and speed up studies

Researchers test new cancer research model that may reduce cost and speed up studies

Experts propose new solutions to increase benefit, affordability of targeted cancer medicines

Experts propose new solutions to increase benefit, affordability of targeted cancer medicines

Study finds link between industry payments and prescription practices for two cancer types

Study finds link between industry payments and prescription practices for two cancer types

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

FDA approved drug found to have anti-cancer activity against previously unknown targets

FDA approved drug found to have anti-cancer activity against previously unknown targets

Existing drugs may be able to improve therapy for chronic myeloid leukemia, mice study shows

Existing drugs may be able to improve therapy for chronic myeloid leukemia, mice study shows

Make Sense campaign aims to promote better quality of life for head and neck cancer survivors

Make Sense campaign aims to promote better quality of life for head and neck cancer survivors

Cancer drug may inhibit growth of cysts in patients with inherited form of kidney disease

Cancer drug may inhibit growth of cysts in patients with inherited form of kidney disease

Study provides new insight into development of immune cells

Study provides new insight into development of immune cells

Novel approach to leukemia therapy can safely improve treatment success, reduce side effects

Novel approach to leukemia therapy can safely improve treatment success, reduce side effects

Researchers identify new drug target for two common types of myeloid leukemia

Researchers identify new drug target for two common types of myeloid leukemia

Formaldehyde exposure not linked to leukemia, research shows

Formaldehyde exposure not linked to leukemia, research shows

Scientists launch new virtual platform to aid global search for treatment of leukemia

Scientists launch new virtual platform to aid global search for treatment of leukemia

Study identifies potential Achilles heel of kinase-driven cancers

Study identifies potential Achilles heel of kinase-driven cancers

GUMC launches phase II clinical study to examine safety of cancer drug for Parkinson's disease

GUMC launches phase II clinical study to examine safety of cancer drug for Parkinson's disease

Salk professor receives inaugural Sjöberg Prize for groundbreaking cancer research

Salk professor receives inaugural Sjöberg Prize for groundbreaking cancer research